One-Shot, One Opportunity: Retrospective Observational Study on Long-Acting Antibiotics for SSTIs in the Emergency Room—A Real-Life Experience
Pathogens · 2025
DOI: 10.3390/pathogens14080781 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pathogens, 2025. Verfasst von Giacomo Ciusa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, ARNAS Civico-Di Cristina Hospital, 90100 Palermo, Italy. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Soft Tissue Infections, Teicoplanin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Skin and soft tissue infections (SSTIs) are a major cause of emergency room (ER) visits and hospitalizations. Long-acting lipoglycopeptides (LALs), such as dalbavancin and oritavancin, offer potential for early discharge and outpatient management, especially in patients at risk for methicillin-resistant Staphylococcus aureus (MRSA) or with comorbidities.
Methods
We conducted a retrospective observational cohort study from March to December 2024 in an Italian tertiary-care hospital. Adult patients treated in the ER with a single dose of dalbavancin (1500 mg) or oritavancin (1200 mg) for SSTIs were included. Demographic, clinical, and laboratory data were collected. Follow-up evaluations were performed at 14 and 30 days post-treatment to assess outcomes.
Results
Nineteen patients were enrolled (median age 59 years; 53% female). Most had lower limb involvement and elevated inflammatory markers. Three patients (16%) were septic. Fourteen patients (74%) were discharged without hospital admission; hospitalization in the remaining cases was due to comorbidities rather than SSTI severity. No adverse drug reactions were observed. At 14 days, 84% of patients had clinical resolution; only 10% had recurrence by day 30, with no mortality nor readmission reported.
Conclusions
LALs appear effective and well-tolerated in the ER setting, supporting early discharge and reducing healthcare burden. Broader use may require structured care pathways and multidisciplinary coordination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit, ARNAS Civico-Di Cristina Hospital, 90100 Palermo, Italy.
- Infectious Diseases Unit, Umberto I Public Hospital, 96100 Siracusa, Italy.
- Emergency Room, ARNAS Civico-Di Cristina Hospital, 90100 Palermo, Italy.
- Pharmacy Unit, ARNAS Civico-Di Cristina Hospital, 90100 Palermo, Italy.
- Infectious Diseases Unit, P. Giaccone University Hospital, 90100 Palermo, Italy.
ORCID-Profile: Giuseppe Pipitone, Antonio Cascio
Zitieren
APA
Ciusa, G., Pipitone, G., Mancuso, A., Agrenzano, S., Imburgia, C., Geraci, A. M., D'Alcamo, A., Moscarelli, L., Cascio, A., & Iaria, C. (2025). One-Shot, One Opportunity: Retrospective Observational Study on Long-Acting Antibiotics for SSTIs in the Emergency Room—A Real-Life Experience. Pathogens. https://doi.org/10.3390/pathogens14080781
Vancouver
Ciusa G, Pipitone G, Mancuso A, Agrenzano S, Imburgia C, Geraci AM, et al. One-Shot, One Opportunity: Retrospective Observational Study on Long-Acting Antibiotics for SSTIs in the Emergency Room—A Real-Life Experience. Pathogens. 2025. doi:10.3390/pathogens14080781
BibTeX
@article{Ciusa2025,
author = {Ciusa, Giacomo and Pipitone, Giuseppe and Mancuso, Alessandro and Agrenzano, Stefano and Imburgia, Claudia and Geraci, Agostino Massimo and D'Alcamo, Alberto and Moscarelli, Luisa and Cascio, Antonio and Iaria, Chiara},
title = {One-Shot, One Opportunity: Retrospective Observational Study on Long-Acting Antibiotics for SSTIs in the Emergency Room—A Real-Life Experience},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14080781}
}
EUVIMED